VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2021 | Unmet needs in the polycythemia vera and essential thrombocythemia

David Ross, MD, PhD, Royal Adelaide Hospital, Adelaide, Australia, Australia, talks on the most pressing unmet needs in the treatment of polycythemia vera and essential thrombocythemia, highlighting the small number of studies in these populations and low tolerance of toxicities. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.

Disclosures

David Ross, MD, PhD, has received research funding and honoraria for lectures and advisory boards from Novartis and BMS/Celgene.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter